Clinical Trial Update: Ascending Dose Study of CT1812 in Healthy Volunteers [Phase 1]

View source ↗

Summary

An ascending-dose Phase 1 study of CT1812 in healthy volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• CT1812

Snippet

Sponsor: Cognition Therapeutics | Conditions: Cognitive Impairment | Phase 1 | Status: COMPLETED